Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: Effect of formulation and route of immunization on induction of Th1 and Th2 cells

Vaccine

Volumn 19, Issue 15-16, 2001, Pages 1940-1950

  Conway, Margaret A ^a   Madrigal Estebas, Laura ^a   McClean, Siobhan ^b   Brayden, David J ^b   Mills, Kingston H G ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Biodegradable microparticle; Bordetella pertussis; Oral immunization

Indexed keywords

CYTOKINE; HEMAGGLUTININ; NANOPARTICLE; PERTUSSIS VACCINE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; NONHUMAN; PARTICLE SIZE; PERTUSSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADHESINS, BACTERIAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BIOCOMPATIBLE MATERIALS; BORDETELLA PERTUSSIS; HEMAGGLUTININS; INJECTIONS; LACTIC ACID; MICE; MICE, INBRED BALB C; MICROSPHERES; PARTICLE SIZE; PERTUSSIS VACCINE; POLYGLYCOLIC ACID; POLYMERS; TH1 CELLS; TH2 CELLS; TOXOIDS; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 0035961506     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00433-3     Document Type: Article

References (39)

1. Biogradation and tissue reaction to 50:50 poly (D, L-lactide-co-glycolide)
2. Biodegradable microspheres for the delivery of oral vaccines
3. Protection against vaginal SIV transmission with microencapsulated vaccine
4. Single dose, polymeric microparticle-based vaccines: The influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen
5. + Th1 cells
6. Immunoglobulin A (IgA); molecular and cellular interactions involved in IgG biosynthesis and immune response
7. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens
8. Overview of the mucosal immune system
9. Controlled vaccine release in the gut associated lymphoid tissues. 1. Orally administered biodegradable microspheres target the Peyer's patches
10. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix and Peyer's patches. An electron microscopic study
11. Intestinal translocation of particulates-implications for drug and antigen delivery
12. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis
13. Cellular immunity in pertussis
14. Bordetella pertussis respiratory infection in children is associated with preferential activation of type1 T helper cells
15. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity
16. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children
17. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines
18. A controlled trial of a two acellular vaccines and one whole cell vaccine against pertussis
19. A controlled trial of two-component acellular, a five-component acellular and a whole cell pertussis vaccine
20. A placebo-controlled trial of a pertussis-toxid vaccine
21. Particle size studies for subcutaneous delivery of poly (lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation
22. Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers
23. In vitro and in vivo characterization of herparin-loaded microspheres
24. Preparation and characterization of poly(lactide-co-glycolide) microparticles. II. Protein entrapment by water-in-oil emulsion solvent evaporation
25. Cell mediated immunity to Bordetella pertussis: Role of Th1 cells in bacterial clearance in a murine respiratory infection model
26. Atypical disease following Bordetella pertussis respiratory infection of mice with target disruptions in IFN-γ receptor or immunoglobin μ chain genes
27. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: Implications for long term immunity in children
28. The control of the antibody isotype response to human immunodeficiency virus gp120 antigen by adjuvants
29. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen presenting populations
30. + T cells. I. Influence of antigen concentration and antigen-presenting cell type
31. The role of antigen presenting cells in the regulation of delayed type hypersensitivity. II Epidermal Langerhans' cells and peritoneal exudate macrophages
32. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles
33. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis
34. B cell memory is short lived in the absence of antigen
35. Orally administered microencapsulated Bordetella pertussis Fimbriae protect mice from B. pertussis respiratory infection
36. Enchanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable particles containing antigen
37. Peyer's patches: An enriched source of precursors for IgA-producing immunocytes in the rabbit
38. Antibodies of the IgA isotype in intestinal plasma cells of germ-free mice after oral or parenteral immunization with ferritin
39. Predominant contribution of IgA antibody-forming cells to an immune response detected in extraintestinal lymphoid tissues of germ-free mice exposed to antigen by the oral route